Insig is a Toronto-based telehealth company that lets patients submit detailed histories and reasons for visits via questionnaires, transforming that information into physician-ready medical notes. The company’s technology supports virtual consultations through video, phone, and secure messaging and will be offered as part of a product called VirtualClinic+. Insig entered a strategic partnership with WELL Health to commercialize its telehealth software to WELL’s patients and providers. Financially, WELL invested $5.94 million and became Insig’s largest shareholder, with WELL’s CEO joining Insig’s board. The financing included a $3.94 million purchase of common shares and a $2 million loan structured as a convertible note. WELL said it will rapidly ramp the program amid increased COVID-19-driven demand and has already onboarded physicians from its corporate clinics in British Columbia and Ontario.

Total raised

$6M

Funding rounds

2

Latest round

Convertible Note

Latest activity

Mar 2020